Amphastar Pharmaceuticals, Inc. (AMPH) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 171.17M | 183.1M | 191.84M | 174.41M | 170.53M | 186.52M | 188.82M | 182.39M | 171.84M | 178.1M | 180.56M | 145.71M |
| Revenue Growth % | 0.38% | -1.83% | 1.6% | -4.38% | -0.76% | 4.73% | 4.58% | 25.17% | 22.72% | 31.91% | 50.3% | 18.02% |
| Cost of Goods Sold | 100.85M | 97.44M | 93.19M | 87.92M | 85.28M | 99.88M | 86.88M | 87.23M | 84.55M | 81.97M | 72.15M | 72.97M |
| COGS % of Revenue | 58.92% | 53.21% | 48.58% | 50.41% | 50.01% | 53.55% | 46.01% | 47.82% | 49.2% | 46.02% | 39.96% | 50.08% |
| Gross Profit | 70.32M | 85.67M | 98.65M | 86.49M | 85.25M | 86.65M | 101.94M | 95.17M | 87.29M | 96.14M | 108.4M | 72.74M |
| Gross Margin % | 41.08% | 46.79% | 51.42% | 49.59% | 49.99% | 46.45% | 53.99% | 52.18% | 50.8% | 53.98% | 60.04% | 49.92% |
| Gross Profit Growth % | -17.51% | -1.13% | -3.23% | -9.12% | -2.34% | -9.87% | -5.96% | 30.83% | 18.22% | 35.09% | 85.27% | 14.81% |
| Operating Expenses | 56.69M | 50.06M | 73.33M | 44.31M | 47.96M | 41.5M | 44.89M | 39.95M | 39.28M | 42.16M | 35.73M | 35.84M |
| OpEx % of Revenue | 33.12% | 27.34% | 38.22% | 25.4% | 28.12% | 22.25% | 23.78% | 21.9% | 22.86% | 23.67% | 19.79% | 24.6% |
| Selling, General & Admin | 29.95M | 26.75M | 50.97M | 24.23M | 27.86M | 23.36M | 23.82M | 22.3M | 25.05M | 21.74M | 19.06M | 19M |
| SG&A % of Revenue | 17.5% | 14.61% | 26.57% | 13.89% | 16.34% | 12.53% | 12.61% | 12.22% | 14.58% | 12.21% | 10.56% | 13.04% |
| Research & Development | 26.74M | 23.31M | 22.35M | 20.08M | 20.1M | 18.14M | 21.08M | 17.65M | 14.23M | 20.42M | 16.66M | 16.84M |
| R&D % of Revenue | 15.62% | 12.73% | 11.65% | 11.51% | 11.78% | 9.73% | 11.16% | 9.68% | 8.28% | 11.46% | 9.23% | 11.56% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 13.63M | 35.61M | 25.32M | 42.18M | 37.29M | 45.14M | 57.05M | 55.22M | 48.01M | 53.98M | 72.68M | 36.9M |
| Operating Margin % | 7.96% | 19.45% | 13.2% | 24.19% | 21.87% | 24.2% | 30.21% | 30.27% | 27.94% | 30.31% | 40.25% | 25.32% |
| Operating Income Growth % | -63.45% | -21.13% | -55.62% | -23.6% | -22.32% | -16.37% | -21.51% | 49.66% | 43.6% | 42.68% | 212.89% | 48.64% |
| EBITDA | 13.63M | 38.54M | 39.45M | 58.42M | 52.5M | 59.81M | 71.48M | 69.36M | 61.97M | 67.77M | 86.25M | 43.92M |
| EBITDA Margin % | 7.96% | 21.05% | 20.56% | 33.5% | 30.79% | 32.06% | 37.86% | 38.03% | 36.07% | 38.05% | 47.77% | 30.14% |
| EBITDA Growth % | -74.04% | -35.55% | -44.81% | -15.77% | -15.29% | -11.75% | -17.12% | 57.94% | 51.79% | 49.71% | 182.29% | 38.75% |
| D&A (Non-Cash Add-back) | 0 | 0 | 14.13M | 16.24M | 15.21M | 14.66M | 14.43M | 14.14M | 13.96M | 13.79M | 13.57M | 7.02M |
| EBIT | 13.63M | 38.54M | 27.8M | 45.62M | 37.15M | 50.39M | 54.38M | 58.85M | 48.01M | 50.8M | 77.34M | 36.41M |
| Net Interest Income | -4.15M | -4.21M | -4.04M | -4.36M | -4.2M | -4.13M | -4.27M | -5.27M | -6.05M | -7.15M | -12.5M | -2.57M |
| Interest Income | 2.4M | 2.42M | 2.25M | 1.92M | 2.09M | 2.29M | 2.43M | 3.34M | 2.56M | 2.3M | 1.2M | 1.03M |
| Interest Expense | 6.55M | 6.63M | 6.28M | 6.28M | 6.29M | 6.42M | 6.7M | 8.61M | 8.61M | 9.46M | 13.7M | 3.6M |
| Other Income/Expense | -3.58M | -3.69M | -3.81M | -2.85M | -6.43M | -1.18M | -9.37M | -4.97M | -707K | -13.14M | -9.43M | -4.39M |
| Pretax Income | 10.05M | 31.91M | 21.51M | 39.34M | 30.86M | 43.96M | 47.68M | 50.24M | 47.3M | 40.84M | 63.25M | 32.51M |
| Pretax Margin % | 5.87% | 17.43% | 11.21% | 22.55% | 18.1% | 23.57% | 25.25% | 27.55% | 27.53% | 22.93% | 35.03% | 22.31% |
| Income Tax | 3.63M | 7.49M | 4.16M | 8.3M | 5.58M | 6M | 7.25M | 12.29M | 4.13M | 4.67M | 14.03M | 6.38M |
| Effective Tax Rate % | 36.13% | 23.45% | 19.35% | 21.11% | 18.07% | 13.64% | 15.21% | 24.47% | 8.72% | 11.44% | 22.17% | 19.64% |
| Net Income | 6.42M | 24.43M | 17.35M | 31.03M | 25.29M | 37.96M | 40.43M | 37.95M | 43.18M | 36.17M | 49.22M | 26.12M |
| Net Margin % | 3.75% | 13.34% | 9.04% | 17.79% | 14.83% | 20.35% | 21.41% | 20.81% | 25.13% | 20.31% | 27.26% | 17.93% |
| Net Income Growth % | -74.61% | -35.65% | -57.09% | -18.23% | -41.44% | 4.97% | -17.86% | 45.26% | 65.86% | 6.65% | 210.08% | 50.61% |
| Net Income (Continuing) | 6.42M | 24.43M | 17.35M | 31.03M | 25.29M | 37.96M | 40.43M | 37.95M | 43.18M | 36.17M | 49.22M | 26.12M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.14 | 0.51 | 0.37 | 0.64 | 0.51 | 0.74 | 0.78 | 0.73 | 0.81 | 0.68 | 0.91 | 0.49 |
| EPS Growth % | -72.55% | -31.08% | -52.56% | -12.33% | -37.04% | 8.82% | -14.29% | 48.98% | 62% | 3.03% | 203.33% | 48.48% |
| EPS (Basic) | 0.14 | 0.53 | 0.38 | 0.66 | 0.53 | 0.78 | 0.83 | 0.78 | 0.90 | 0.75 | 1.01 | 0.54 |
| Diluted Shares Outstanding | 46.46M | 47.16M | 47.68M | 48.13M | 49.89M | 52.06M | 51.86M | 52.05M | 53.01M | 53.01M | 53.92M | 53.1M |
| Basic Shares Outstanding | 45.32M | 45.91M | 46.47M | 46.95M | 47.64M | 48.43M | 48.62M | 48.91M | 48.21M | 47.96M | 48.7M | 48.4M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |